AU2119101A - Ligand chelated paramagnetic mri contrast agents - Google Patents

Ligand chelated paramagnetic mri contrast agents

Info

Publication number
AU2119101A
AU2119101A AU21191/01A AU2119101A AU2119101A AU 2119101 A AU2119101 A AU 2119101A AU 21191/01 A AU21191/01 A AU 21191/01A AU 2119101 A AU2119101 A AU 2119101A AU 2119101 A AU2119101 A AU 2119101A
Authority
AU
Australia
Prior art keywords
contrast agents
mri contrast
chelated paramagnetic
ligand chelated
paramagnetic mri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21191/01A
Inventor
Robert E. Carraway
Lech Dudycz
Craig F. Ferris
Jean A. King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insight Neuroimaging Systems LLC
Original Assignee
Insight Neuroimaging Systems LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insight Neuroimaging Systems LLC filed Critical Insight Neuroimaging Systems LLC
Publication of AU2119101A publication Critical patent/AU2119101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AU21191/01A 1999-10-22 2000-10-20 Ligand chelated paramagnetic mri contrast agents Abandoned AU2119101A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16099099P 1999-10-22 1999-10-22
US16093399P 1999-10-22 1999-10-22
US60160990 1999-10-22
US60160933 1999-10-22
PCT/US2000/041385 WO2001030398A2 (en) 1999-10-22 2000-10-20 Ligand chelated paramagnetic mri contrast agents

Publications (1)

Publication Number Publication Date
AU2119101A true AU2119101A (en) 2001-05-08

Family

ID=26857346

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21191/01A Abandoned AU2119101A (en) 1999-10-22 2000-10-20 Ligand chelated paramagnetic mri contrast agents

Country Status (2)

Country Link
AU (1) AU2119101A (en)
WO (1) WO2001030398A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284539B (en) 2001-07-30 2007-08-01 Epix Pharm Inc A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide
US6987270B2 (en) 2003-05-07 2006-01-17 General Electric Company Method to account for event losses due to positron range in positron emission tomography and assay of positron-emitting isotopes
US9339559B2 (en) 2005-09-09 2016-05-17 Georgia State University Research Foundation, Inc. Targeted contrast agents and methods for targeting contrast agents
EP1928507B1 (en) * 2005-09-09 2015-11-11 Georgia State University Research Foundation, Inc. Targeted contrast agents and methods for targeting contrast agents
EP2518155B1 (en) 2006-08-04 2014-07-23 Georgia State University Research Foundation, Inc. Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
CA2671431C (en) 2006-12-14 2019-03-26 Georgia State University Research Foundation, Inc. Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
EP2257316B1 (en) 2008-04-02 2018-11-07 Georgia State University Research Foundation, Inc. Contrast agents, methods for preparing contrast agents, and methods of imaging
WO2011006985A1 (en) * 2009-07-16 2011-01-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors
US9956304B2 (en) 2012-06-05 2018-05-01 Georgia State University Research Foundation, Inc. Contrast agents, methods for preparing contrast agents, and methods of imaging
WO2023279073A1 (en) * 2021-07-01 2023-01-05 Amicus Therapeutics, Inc. Neurotensin variants and tagged proteins comprising neurotensin or sortilin propeptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022341A1 (en) * 1994-02-18 1995-08-24 Mallinckrodt Medical, Inc. Labelled peptide compounds
US6312661B1 (en) * 1997-02-03 2001-11-06 Mallinckrodt Inc. Method for the detection and localization of ductal exocrine pancreas tumours
EP1194444A2 (en) * 1999-06-24 2002-04-10 BioSynthema Inc. Labeled neurotensin derivatives with improved resistance to enzymatic degradation

Also Published As

Publication number Publication date
WO2001030398A2 (en) 2001-05-03
WO2001030398A3 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
IL145839A0 (en) ESTROGEN RECEPTOR-β LIGANDS
HUP0202442A3 (en) Multiple cytokine-antibody complexes
AU5753601A (en) Functional mri agents for cancer imaging
AU2001276956A1 (en) Macrocyclic mri contrast agents
IL153539A0 (en) Protein complexes and methods for the preparation thereof
AU2119101A (en) Ligand chelated paramagnetic mri contrast agents
GB9924205D0 (en) Magnetic fastener
GB9802022D0 (en) Complexing agents
GB9923928D0 (en) Coils integrated in ic-package
SG87181A1 (en) Magnetic media tester
GB0012054D0 (en) Ligands
GB9912743D0 (en) Method and kit for ligand assay
GB9915114D0 (en) Trailers
AU3225900A (en) Ph sensitive mri contrast agents
IL150890A0 (en) Novel ligands and methods for preparing same
GB2352524B (en) Trailer noseweight indicator
AU2316100A (en) Complexing agents
GB9927157D0 (en) Releasable Ligand
GB9927014D0 (en) Mr probes
GB9923812D0 (en) Ligand design
GB0004962D0 (en) Macrocyclic ligands and complexes thereof
GB9927536D0 (en) Magnetic motor
EP1240358A4 (en) T1 receptor-like ligand ii and uses thereof
GB9903823D0 (en) Schiefs base complexes
GB2355012B (en) Paramagnetic polymer practice

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase